论文部分内容阅读
原发性肝癌是我国常见的恶性肿瘤之一,近年来发病率呈上升趋势,全世界每年新增30万～100万病例,且已居我国癌症的第二位,在城市仅次于肺癌,在农村次于胃癌,年病死率为1.46～4.60/万,平均2.04/万。我国每年因肝癌而死亡的人数约20余万,约占世界肝癌死亡人数45%[1]。目前临床较常
Primary liver cancer is one of the common malignant tumors in our country. In recent years, the incidence is on the rise. The number of new cases in the world is 300,000 to 1,000,000 each year. It ranks second in China’s cancer, second only to lung cancer, In rural areas after gastric cancer, the annual mortality rate of 1.46 ~ 4.60 / million, an average of 2.04 / million. About 200,000 people die of liver cancer each year in our country, accounting for about 45% of the world’s liver cancer deaths [1]. Currently more clinically